Do allelic variants in α2A and α2C adrenergic receptors predispose to hypertension in blacks?

Hypertension

Volumn 47, Issue 6, 2006, Pages 1140-1146

  Li, Jia Ling ^a   Canham, Russell M ^a   Vongpatanasin, Wanpen ^a   Leonard, David ^a   Auchus, Richard J ^a   Victor, Ronald G ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Hypertension, genetics; Polymorphisms; Receptors, adrenergic alpha; Sympathetic nervous system

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; DNA; ADRENERGIC RECEPTOR ALPHA(2C); ALPHA 2 ADRENERGIC RECEPTOR; RECEPTOR, ADRENERGIC, ALPHA 2A; RECEPTOR, ADRENERGIC, ALPHA-2A;

ADULT; AGE; ALLELE; ARTERY COMPLIANCE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; GENE DELETION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEART OUTPUT; HEART RATE; HOME; HUMAN; HYPERTENSION; INTERVIEW; MALE; NEGRO; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION SIZE; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SAMPLE SIZE; SMOKING; STATISTICAL MODEL; SYSTEMIC VASCULAR RESISTANCE; AGED; BLOOD PRESSURE; GENETICS; HEART MUSCLE; HEART VENTRICLE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ALLELES; BLOOD PRESSURE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEART VENTRICLES; HUMANS; HYPERTENSION; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; RECEPTORS, ADRENERGIC, ALPHA-2; VARIATION (GENETICS);

EID: 33744967315     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000217972.80731.ef     Document Type: Article

References (32)

1. Barnett E, Casper ML, Halverson JA, Elmes GA, Braham VE. Men and Heart Disease: An Atlas of Racial and Ethnic Disparities in Mortality. Atlanta, GA: Centers for Disease Control and Prevention; 2001.
2. Casper ML, Barnett E, Halverson JA, Elmes GA, Braham VE, Majeed Z, Bloom A, Stanley S. Women and Heart Disease. An Atlas of Racial and Ethnic Disparities in Mortality. 2nd ed. Atlanta, GA: Centers for Disease Control and Prevention; 2003:239.
3. Cooper R. The role of genetic and environmental factors in cardiovascular disease in African Americans. Am J Med Sci Mar. 1999;317:208-213.
4. Douglas JG, Bakris GL, Epstein M, Ferdinand KC, Ferrario C, Flack JM, Jamerson KA, Jones WE, Haywood J, Maxey R, Ofili EO, Saunders E, Schiffrin EL, Sica DA, Sowers JR, Vidt DG. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. 2003;163:525-541.
5. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199-206.
6. American Heart Association. Heart Disease and Stroke Statistics - 2005 Update. Dallas, TX: Am Heart Association; 2004.
7. Cooper RS, Psaty BM. Genomics and medicine: distraction, incremental progress, or the dawn of a new age? Ann Intern Med. 2003;138:576-580.
8. 2-adrenergic receptor increases autonomic responses to stress. J Appl Physiol. 2004;96:2231-2239.
9. 2C-adrenergic receptor confers impaired coupling to multiple effectors. J Biol Chem. 2000;275:23059-23064.
10. 2- Adrenergic receptor subtypes - novel functions uncovered in gene-targeted mouse models. Biol Cell. 2004;96:343-348.
11. 2-Adrenergic receptor gene polymorphism and hypertension in blacks. Am J Hypertens. 1995;8:390-394.
12. 2-adrenergic receptor is associated with increased platelet aggregation, baroreceptor sensitivity, and salt excretion in normotensive humans. Am J Hypertens. 1995;8:863-869.
13. 2C-adrenoreceptor gene polymorphism in healthy humans. Pharmacogenet Genomics. 2005;15:143-149.
14. 2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med. 2002;347:1135-1142.
15. Victor RG, Haley RW, Willett D, Peshock RM, Vaeth PC, Leonard D, M. B., Cooper RS, Iannacchione VG, Visscher W, Staab J, Hobbs HH. The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol. 2004;93:1473-1480.
16. Drazner MH, Dries DL, Peshock RM, Cooper RS, Klassen C, Kazi F, Willett D, Victor RG. Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study. Hypertension. 2005;46:124-129.
17. Mohiaddin RH, Underwood SR, Bogren HG, Firmin DN, Klipstein RH, Rees RS, Longmore DB. Regional aortic compliance studied by magnetic resonance imaging: the effects of age, training, and coronary artery disease. Br Heart J. 1989;62:90-96.
18. Jones CR, Taylor K, Poston L, Shennan AH. Validation of the Welch Allyn 'Vital Signs' oscillometric blood pressure monitor. J Hum Hypertens. 2001;15:191-195.
19. Dabl. Dabl Educational Trust. Available at: www.dableducational.com. Accessed November 2005.
20. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
21. 2A knockout mice. Br J Pharmacol. 2004;141:851-859.
22. 2A-adrenergic receptor knockout mice. Mol Pharmacol. 1999;56:154-161.
23. 2-adrenergic receptors regulate sympathetic neurotransmission. Nature. 1999;402:181-184.
24. 2- adrenoceptor subtypes. Mol Endocrinol. 2003;17:1640-1646.
25. 2-adrenoceptor subtypes prevents progression of heart failure. Circulation. 2002;106:2491-2496.
26. Julius S, Krause L, Schork NJ, Mejia AD, Jones KA, van de Ven C, Johnson EH, Sekkarie MA, Kjeldsen SE, Petrin J, Schmouder R, Gupta R, Ferraro J, Nazzaro P, Weissfeld J. Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertens. 1991;9:77-84.
27. Jiang X, Srinivasan SR, Urbina E, Berenson GS. Hyperdynamic circulation and cardiovascular risk in children and adolescents. The Bogalusa Heart Study. Circulation. 1995;91:1101-1106.
28. Palatini P, Julius S. Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens. 2004;26:637-644.
29. Folkow B. The debate on the amplifier hypothesis' - some comments. J Hypertens. 2000;18:375-378.
30. 2C-adrenergic receptors: Diverse intragenic variability with haplotype-specific functional effects. Proc Natl Acad Sci U S A. 2004;101:13020-13025.
31. Dries DL, Victor RG, Rame JE, Cooper RS, Wu X, Zhu X, Leonard D, Ho SI, Wu Q, Post W, Drazner MH. Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation. 2005;112:2403-2410.
32. Hollier JM, Martin DF, Bell DM, Li JL, Chirachanchai MG, Menon DV, Leonard D, Wu X, Cooper RS, McKenzie C, Victor RG, Auchus RJ. Epithelial sodium channel allele T594M is not associated with blood pressure or blood pressure response to amiloride. Hypertension. 2006;47:428-433.